Studies
D7480C00001, AZD7760, End stage renal disease
Internal Medicine
Nephrology
Kidney Disease
Vascular Disease
Healthy Subjects
Adult Subjects
The purpose of this study is to evaluate the safety and pharmacokinetics (PK) of AZD7760 when given as an intravenous infusion to healthy participants (Phase I) or participants with end-stage kidney disease receiving hemodialysis through a central venous catheter (Phase IIa).
SCD-006; Selective Cytopheretic Device for AKI
Internal Medicine
Kidney Failure
Adult Subjects
A PHASE 3 RANDOMIZED CONTROLLED STUDY OF RENAL AUTOLOGOUS CELL THERAPY (REACT) IN SUBJECTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE (REGEN-006)
Internal Medicine
Endocrinology
Nephrology
Diabetes
Kidney Disease
Adult Subjects
The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.